The cell line models to study tyrosine kinase inhibitors in non-small cell lung cancer with mutations in the epidermal growth factor receptor: A scoping review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The cell line models to study tyrosine kinase inhibitors in non-small cell lung cancer with mutations in the epidermal growth factor receptor: A scoping review

Published:2024-02 Issue: Volume:194 Page:104246
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Belloni Alessia,Pugnaloni Armanda,Rippo Maria Rita,Di Valerio Silvia,Giordani Chiara,Procopio Antonio Domenico,Bronte Giuseppe^ORCID

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference265 articles.

1. Gefitinib induces cytoplasmic translocation of the CDK inhibitor p27 and its binding to a cleaved intermediate of caspase 8 in non-small cell lung cancer cells;Ahn;Cell. Oncol. (Dordr. ).,2014

2. CD133-positive cells from non-small cell lung cancer show distinct sensitivity to cisplatin and afatinib;Alama;Arch. Immunol. Ther. Exp. (Warsz. ).,2015

3. Defining the sensitivity landscape of EGFR variants to tyrosine kinase inhibitors;An;Transl. Res.,2023

4. Sequence-dependent synergistic effect of aumolertinib-pemetrexed combined therapy on EGFR-mutant non-small-cell lung carcinoma with pre-clinical and clinical evidence;Ao;J. Exp. Clin. Cancer Res.,2022

5. Resminostat, a histone deacetylase inhibitor, circumvents tolerance to EGFR inhibitors in EGFR-mutated lung cancer cells with BIM deletion polymorphism;Arai;J. Med. Invest.,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP